Literature DB >> 7780876

How to reduce the risk factors of osteoporosis in Asia.

P C Kao1, F K P'eng.   

Abstract

Osteoporosis can be predicted to be a new burden to public health in Asia. Currently, the incidence of osteoporosis-related fractures is lower there than in most western communities. By the year 2050, however, 50% of the 6.3 million hip fractures which occur worldwide will be in Asians as a result of an aging population, a decrease in physical activity and westernization of lifestyles. The cost of treatment and cure of these patients will be enormous, a sufficient financial burden to consume current economic gain and cripple the future advancing development of Asian countries. Individual risk factors for osteoporosis have been identified by the extensive Mediterranean Osteoporosis Study (MEDOS). Fortunately, Asians, the rural population and farmers in particular, have the favorable lifestyle identified by the study, including high physical activity and exposure to sunlight. Strikingly, tea drinking, a daily habit in Asia, is also identified as a protective factor against osteoporosis. In addition, bioflavonoids and phytoestrogen-rich soybeans and vegetables are consumed in large quantities by Asians. A soy diet reduces mortality in breast and prostate cancer because it contains weak estrogens. The weakly estrogenic phytoestrogens require further study to demonstrate their pharmacological effect in reducing the rate of osteoporosis. Public health education, however, is needed to encourage the Asian population to maintain their traditionally good lifestyle and to reduce the risk factors for osteoporosis. In turn, these steps may reduce the public health burden by 2050.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780876

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi (Taipei)        ISSN: 0578-1337


  3 in total

1.  Xeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor.

Authors:  Hao Wang; Jiang Li; Yang Gao; Ying Xu; Ying Pan; Ichiro Tsuji; Zi-Jie Sun; Xiao-Meng Li
Journal:  Asian J Androl       Date:  2010-05-03       Impact factor: 3.285

2.  Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis.

Authors:  Pauline Siew Mei Lai; Siew Siang Chua; Siew Pheng Chan
Journal:  Int J Clin Pharm       Date:  2013-05-16

Review 3.  Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective.

Authors:  Elisabetta Poluzzi; Carlo Piccinni; Emanuel Raschi; Angela Rampa; Maurizio Recanatini; Fabrizio De Ponti
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.